These four biomarkers were selected due to their complementary roles in vascular tone regulation, including endothelial relaxation (NO and prostacyclin), vasoconstriction (noradrenaline), and angiogenic signaling (apelin), all of which are known to be altered in PCOS. The gene discussed is APLN; the disease is polycystic ovary syndrome.